Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|January 1, 2004
- Volume 0 0
Report Cautions Use of Home Testing Kits
Advertisement
Report Cautions Use of HomeTesting Kits
A recent article in JohnsHopkins University?s Health After50 Medical Letter saidhome cholesterol testing kits can give inaccurate and incomplete results. In anexamination of 5 popular home cholesterol tests, the researchers discoveredthat 2 were inaccurate, 2 gave inadequate information, and all required asubstantial blood sample. The article recommends that patients notallow home testing kits to replace having their cholesteroltested by their physician.
Articles in this issue
over 22 years ago
GER Is Common Among Children with Bronchial Asthmaover 22 years ago
Not All GERD Patients Are Alikeover 22 years ago
Chronic Constipation Makes Headlinesover 22 years ago
Dyspepsia and Gastric Emptying in Diabeticsover 22 years ago
New Indications: 2003over 22 years ago
Can You Read These Rxs? Answersover 22 years ago
Compounding Hotlineover 22 years ago
Sleep Apnea Is Tied to Depression?over 22 years ago
Women Are Shortchanged on Getting Shut-Eyeover 22 years ago
RLS Runs in the FamilyAdvertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
Radioligand Therapy Doesn’t Need to Be Risk-Free—It Needs to Be Worth It
3
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
4
FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A
5